期刊文献+

HLA-DR^(neg/low)急性单核细胞白血病的免疫学表型分析 被引量:1

Immunophenotype analysis of acute monocytic leukemia with HLA-DR^(neg/low)
下载PDF
导出
摘要 目的探讨不表达或低比例表达HLA-DR(HLA-DR^(neg/low))急性单核细胞白血病(AML-M5)患者的免疫学表型特征。方法用多参数流式细胞术对111例急性单核细胞白血病(AML-M5)患者的骨髓细胞进行检测,分析其免疫表型。结果流式细胞术结果表明,HLA-DR抗原阴性表达者(HLA-DR^(neg))9例,低表达者(HLA-DR^(low))2例,且均表达CD13和CD33,不表达CD4,而CD34、CD38、CD117、CD15、CD64、CD14和CD56均呈异质性表达;与HLA-DR^(posi)阳性者相比,HLA-DR^(neg)/low者CD4的阳性率差异有统计学意义(P=0.015),其他抗原阳性率的差异均无统计学意义。结论 HLA-DR^(neg/low)的AML-M5患者CD抗原表达异常,多呈HLA-DR^(neg/low)/CD4^(neg)的表型特征,极易被误诊为其他类型的白血病。 Objective To investigate the immunophenotype characteristics of acute monocytic leukemia( AML-M5) with HLA-DR^(neg/low).Methods Bone marrow cells from 111 patients with AML-M5 were determined with multiparameter flow cytometry,and their immunophenotypes were analyzed. Results Among 111 patients with AML-M5,11 were identified to be HLA-DR^(neg/low),including 9 negative and 2 low expression. All of 11 patients expressed CD13 and CD33,and didn' t express CD4. Other antigens,such as CD34,CD38,CD117,CD15,CD64,CD14 and CD56,were variously expressed. There was significant difference in the positive rate of CD4 between HLA-DRposi and HLA-DR^(neg/low)( P =0. 015),but not in the other antigens. Conclusion The AML-M5 patients with HLA-DR^(neg/low) have abnormal expressions of CD antigens,and don't express CD4,which are easy to be misdiagnosed as other types of leukemia.
出处 《临床检验杂志》 CAS CSCD 2016年第1期14-16,共3页 Chinese Journal of Clinical Laboratory Science
基金 国家自然科学基金(81271911) 河南省医学科技攻关重点项目(201002006)
关键词 急性单核细胞白血病 HLA-DR 免疫表型 CD4 acute monocytic leukemia HLA-DR immunophenotype CD4
  • 相关文献

参考文献2

二级参考文献24

  • 1张之南.血液病诊断与疗效标准[M].2版.北京:科学技术出版社,1998:279
  • 2Louche F,Debili N, Marandin A, et al. Expression of CD4 by Humanbematopoietic Progenitors[J]. Blood, 1994,84 : 3344.
  • 3Venditti A. Poeta G D,Bueeisano F. et al. Minimally Differentiated Acute Myeloid Leukemia(AML-Mn):Comparison of 25 Cases with other French-American-British Subtypes[J]. Blood, 1997,89 : 621.
  • 4Bennett JM,Catovsky D,Daniel MT,et al.Proposals for the clas-sification of the acute leukaemias.French-American-British(FAB)co-operative group.Br J Haematol,1976;33(4):451-458.
  • 5Vardiman JW,Imbert M,Pierre R,et al.Chronic myelomono-cytic leukemia.In:Jaffe ES,Harris NL,Stein H,et al,editors.World Health Organization classification of tumors:pathology andgenetics of tumours of haematopoietic and lymphoid tissues.Lyon:IARC Press,2001:49-52.
  • 6Stetler-Stevenson M,Arthur DC,Jabbour N,et al.Diagnosticutility of flow cytometric immunophenotyping in myelodysplasticsyndrome.Blood,2001;98(4):979-987.
  • 7BénéM.Immunophenotyping of myelodysplasia.Haematologica.2003;88(4):363.
  • 8Subira D,Font P,Villalon L,et al.Immunophenotype in chronicmyelomonocytic leukemia:is it closer to myelodysplastic syndro-mes or to myeloproliferative disorders?Transl Res,2008;151(5):240–245.
  • 9Ngo NT,Lampert IA,Naresh KN.Bone marrow trephinemorphology and immunohistochemical findings in chronic myelo-monocytic leukaemia.Br J Haematol,2008;141(6):771-781.
  • 10Kern W,Bacher U,Haferlach C,et al.Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia sharecommon immunopheno-typic features but differ in the extent ofaberrantly expressed antigens and amount of granulocytic cells.Leukemia Lymphoma,2011;52(1):92-100.

共引文献19

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部